Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZW) EBT Margin (2021 - 2025)

Core Scientific (CORZW) has disclosed EBT Margin for 5 consecutive years, with 270.87% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 57719.0% to 270.87% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 90.29% through Dec 2025, up 19111.0% year-over-year, with the annual reading at 90.29% for FY2025, 19111.0% up from the prior year.
  • EBT Margin hit 270.87% in Q4 2025 for Core Scientific, up from 177.43% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 724.87% in Q1 2025 to a low of 1191.23% in Q2 2025.
  • Historically, EBT Margin has averaged 161.13% across 5 years, with a median of 86.99% in 2023.
  • Biggest five-year swings in EBT Margin: crashed -63207bps in 2024 and later soared 60725bps in 2025.
  • Year by year, EBT Margin stood at 25.5% in 2021, then tumbled by -1576bps to 376.36% in 2022, then surged by 63bps to 137.64% in 2023, then crashed by -123bps to 306.32% in 2024, then skyrocketed by 188bps to 270.87% in 2025.
  • Business Quant data shows EBT Margin for CORZW at 270.87% in Q4 2025, 177.43% in Q3 2025, and 1191.23% in Q2 2025.